IGFBP3 and glioblastoma: To further validate the contribution of these pathways to 12ADT-mediated cytotoxicity, we designed CRISPR guides against three target genes (ERN1, IGFBP3, IGFBP5) and transfected them separately into U251 glioblastoma cells.